New trends in face rejuvenation by hyaluronic acid injections

Journal of Cosmetic Dermatology

Volumn 7, Issue 4, 2008, Pages 251-258

  Andre, Pierre ^a  

^a Paris Université Laser Skin Clinic   (France)

Author keywords

Filler; Hyaluronan interactions; Hyaluronic acid; Rejuvenation; Volume restoration

Indexed keywords

HYALURONIC ACID;

CHIN; ESTHETICS; FACE MALFORMATION; FACE REJUVENATION; FACIES; HUMAN; LONGEVITY; PATIENT SAFETY; PRIORITY JOURNAL; REJUVENATION; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE; TREND STUDY; WRINKLE;

CHIN; COSMETIC TECHNIQUES; DERMATOLOGIC AGENTS; EYEBROWS; FACE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; NOSE; PATIENT SATISFACTION; REJUVENATION; RHYTIDOPLASTY; SKIN AGING; TREATMENT OUTCOME;

EID: 56149093364     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2008.00402.x     Document Type: Review

References (23)

1. Andre P. Evaluation of the safety of a non animal stabilized hyaluronic acid (NASHA -Q-med, Sweden) in European countries: A retrospective study from to 2001. J Eur Acad Dermatol Venereol 2004; 18: 422-5.
2. Klein AW. Soft tissue augmentation 2006: Filler fantasy. Dermatol Ther 2006; 19: 129-33.
3. Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: A clinical, histologic and electron microscopic evaluation. Dermatol Surg 2006; 32: 1467-72.
4. Lowe NJ, Grover R. Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg 2006; 32: 881-5.
5. Andre P, Levy P. Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection. J Cosmet Dermatol 2007; 6: 159-62.
6. Trepsat F. Peri-orbital rejuvenation combining fat grafting and blepharoplasties. Aesthetic Plast Surg 2003; 27: 243-53.
7. Klein AW. In favor of double testing. J Dermatol Surg Oncol 1989; 15: 263.
8. Andre P, Lowe NJ, Parc A, Clerici T, Zimmerman U. Adverse reactions to dermal fillers: A review of European experiences. J Cosmet Laser Ther 2005; 7: 171-6.
9. Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shaw K. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol 2001; 45: 930-3.
10. Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007; 72: 430-41.
11. Hayloc DN, Nilsson SK. The role of hyaluronic acid in hemopoietic stem cell biology. Regen Med 2006; 1: 437-45.
12. Goueffic Y, Guilluy C, Guerin P, Patra P, Pacaud P, Loirand G. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent RAC activation. Cardiovasc Res 2006; 72: 339-48.
13. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001; 276: 36770-8.
14. Slevin M, Krupinski J, Gaffrey G et al. Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007; 26: 58-68.
15. Chang EJ, Kim HJ, Ha J et al. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci 2007; 120: 166-76.
16. Barkhuyzen A, Bennett RM. Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. J Rheumatol 1999; 26: 2063-4.
17. Freitas JP, Filipe P, Emerit I, Meunier P, Manso CF, Guerra Rodrigo F. Hyaluronic acid in progressive systemic sclerosis. Dermatology 1996; 192: 46-9.
18. Duruöz MT, Turan Y, Cerrahoglu L, Isbilen B. Serum hyaluronic acid levels in patients with ankylosing spondylitis. Clin Rheumatol 2008; 27: 621-6.
19. Stern R, Asari AA, Sugahara K. Hyaluronan fragments: An information-rich system. Eur J Cell Biol 2006; 85: 699-715.
20. 2 production via CD44 in interleukin-1-stimulated subacromial synovial fibroblasts from patients with rotator cuff disease. J Orthop Res 2008; 26: 1032-7.
21. Kang SW, Bada LP, Kang CS, et al. Articular cartilage regeneration with microfracture and hyaluronic acid. Biotechnol Lett 2008; 30: 435-9.
22. Kim Y, Lee YS, Hahn JH, et al. Hyaluronic acid targets CD44 and inhibits Fc∈RI signaling involving PKCδ, Rac1, ROS, and MAPK to exert anti-allergic effect. Mol Immunol 2008; 45: 2537-47.
23. Wang F, Garza LA, Kang S, et al. In.vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007; 143: 155-63.